Nation | by Bernadine Mutanu
Kenya is among low and middle-income countries which will benefit from The Vaccine Alliance’s (Gavi) funding to make the Covid-19 vaccine available at the earliest time possible.
Last week, Gavi announced that it had approved $150 million (about Sh16 billion) initial funding to 92 low and middle-income countries eligible for the Covid-19 vaccine advance market commitment programme (Covax AMC) which Kenya is part of, to make available Covid-19 vaccines…
